Healthtech
Healthtech
+2
Jun 25, 2026
•
1 min read
BioSapien wins Abu Dhabi regulatory approvals to begin Phase I cancer trials for its MediChip platform
The Department of Health, the Emirates Drug Establishment and an institutional review board have cleared the 3D-printed chemotherapy implant for first-in-human trials, with patient enrolment in colorectal cancer expected to begin within weeks.
Startups
+4
May 15, 2026
•
1 min read
Saudi-based Aumet raises $12M Series A led by Emkan Capital to scale AI procurement platform
The platform processes over $1B in GMV annually, connecting over 12,000 pharmacies across Jordan, Egypt and Saudi Arabia with more than 1,000 pharmaceutical suppliers.
Startups
+5
Mar 31, 2026
•
4 min read
Egyptian-American founder Will Ahmed's Whoop raises $575m at $10.1bn valuation with QIA, Mubadala and 2PointZero all participating
Whoop now has over 2.5 million members globally, was cash flow positive in 2025 and doubled bookings year on year to a $1.1 billion run rate.
Startups
+5
Feb 12, 2026
•
3 min read
Libyan-born founder Abdel Mahmoud's Anterior raises $40M, bringing total funding to $64M for AI-powered clinical review platform
Backed by Sequoia Capital, NEA, FPV Ventures, and Kinnevik, the company now supports organisations covering 50 million lives across major US health plans.
Startups
+4
Jan 13, 2026
•
2 min read
Saudi-based Madeed raises $400K as Eight Sleep exit founder Adam Bataineh launches preventative health and longevity platform
The round was led by Vision Ventures, with participation from Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
Healthtech
+3
Nov 19, 2025
•
2 min read
Nabta Health raises $2M pre-Series A to scale AI-powered women’s health platform
The UAE-based startup brings total funding to USD 4.5 million as it accelerates a hybrid care model spanning digital, at-home and in-clinic services across MEA.
Healthtech
+3
Jul 9, 2025
•
2 min read
BioSapien extends Pre-Series A to over $8M as Globivest joins Global Ventures, Golden Gate in backing MediChipTM
The UAE and US-based healthtech startup is developing a 3D-printed, slow-release drug delivery platform for localised cancer treatment, with new capital supporting global expansion and senior hires across R&D, regulatory, and medical affairs.
